EPHA2 and cutaneous melanoma: This difference in SNV profile between the two genes likely reflects the high frequency of somatic mutations identified in TP53 versus EPHA2. Currently, the COSMIC database lists over 29,480 somatic mutations in TP53 including 17,166 missense substitutions that have been detected in multiple tumor samples (e.g. cutaneous melanoma) at relatively high frequencies (~27%).